Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-010102
Filing Date
2008-02-13
Accepted
2008-02-13 16:47:15
Documents
2
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 rrd195032.html 5  
1 FORM 5 rrd195032.xml 5 10782
2 POWER OF ATTORNEY rrd173950_196504.htm EX-24. 5075
  Complete submission text file 0001181431-08-010102.txt   17660
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MAVERICK CAPITAL, LTD. 101 CALIFORNIA STREET, SUITE 4015 SAN FRANCISCO CA 94111
Business Address 408 731 5000
SINGER DAVID B (Reporting) CIK: 0001240366 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-50679 | Film No.: 08605700